4//SEC Filing
Lee Tien-Li 4
Accession 0001193125-25-204233
CIK 0001774857other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 6:15 AM ET
Size
7.6 KB
Accession
0001193125-25-204233
Insider Transaction Report
Form 4
Lee Tien-Li
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2025-09-15$9.51/sh+6,500$61,819→ 1,539,884 total - Purchase
Common Stock
2025-09-15$9.94/sh+3,500$34,805→ 1,543,384 total
Holdings
- 1,474,028(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.9045 to $9.89 per share, inclusive. The reporting person undertakes to provide Aardvark Therapeutics, Inc. ("Aardvark"), any security holder of Aardvark, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $9.93 to $9.9798 per share, inclusive. The reporting person undertakes to provide Aardvark, any security holder of Aardvark, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Aardvark Therapeutics, Inc.
CIK 0001774857
Entity typeother
Related Parties
1- filerCIK 0001940120
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 6:15 AM ET
- Size
- 7.6 KB